SELECT FROM MENU

Therapy Area
Drug Classes

       Disease Area

All Sessions

All Sessions

All Sessions

Resectable NSCLC

All Sessions

Metastatic NSCLC

All Sessions

SCLC

All Sessions

Biomarkers

       Drug Class

Targeted Therapies

Targeted Therapies

Immuno-therapies

Immuno-therapies

Antibody-Drug Conjugates

Antibody-Drug Conjugates

Stephen Liu

Stephen Liu

Georgetown Lombardi Cancer Center, Washington DC

Dr. Stephen V. Liu is Chief of the Division of Hematology and Oncology at MedStar Georgetown University Hospital and Associate Professor of Medicine at the Lombardi Comprehensive Cancer Center, Georgetown University, in Washington DC, where he previously served as Director of Thoracic Oncology and Head of Developmental Therapeutics. His research centers on rational drug development and novel small-molecule and immunotherapy strategies in advanced thoracic malignancies, and he leads national and international clinical trials in non-small cell and small cell lung cancer, including work on ROS1-targeted therapy. He co-hosts the IASLC official podcast Lung Cancer Considered and is a frequent speaker at major international thoracic oncology congresses.

Connect

Stephen Liu

Featured in

Indication Areas

All Sessions

All Sessions

Resectable NSCLC

Resectable NSCLC

Metastatic Lung Cancer

Metastatic NSCLC

Lung Cancer

SCLC

Biomarkers

Biomarkers & Diagnostics

DRUG CLASSES

Pill

Targeted Therapies

OncoNews

Immunotherapies

Antibody Drug Conjugates

Antibody-Drug Conjugates